@inproceedings{inproceedings, title = {{The North Trent experience of the use of first line pembrolizumab in stage IIIB/IV non-small cell lung cancer}}, publisher = {{Elsevier BV}}, url = {{}}, year = {{2019}}, month = {{1}}, author = {{Elmushraf R and Clinch H and Salawu A and Fisher P and Young R and Lee C and Danson S and Bates E and Hatton M and Low L and Das T et al}}, doi = {{10.1016/s0169-5002(19)30145-x}}, volume = {{127}}, journal = {{Lung Cancer}}, pages = {{S43-S43}}, note = {{Accessed on 2025/09/04}}}